Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAttovia Therapeutics Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.65 | -$0.65 | -$0.65 |
| Q2 2026 | 1 | -$0.56 | -$0.56 | -$0.56 |
| Q3 2026 | 1 | -$0.49 | -$0.49 | -$0.49 |
| Q1 2027 | 1 | -$0.44 | -$0.44 | -$0.44 |
| Q2 2027 | 1 | -$0.44 | -$0.44 | -$0.44 |
Attovia Therapeutics Inc. Earnings Date And Information
Attovia Therapeutics Inc. last posted its earnings results on Wednesday, September 2nd, 2026. The company reported $-4.88 earnings per share for the quarter, missing analysts' consensus estimates of $-0.6459 by $4.2341. The company had revenue of 450.00 K for the quarter and had revenue of 1.35 M for the year. Attovia Therapeutics Inc. has generated $-1 earnings per share over the last year ($-1.42 diluted earnings per share) and currently has a price-to-earnings ratio of -16.17. Attovia Therapeutics Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Attovia Therapeutics Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/02/2026 | Q2 2026 | -$0.65 | -$0.45 | 0.2 | $316.67 K | $450.00 K |
| 03/30/2026 | Q1 2026 | N/A | -$0.48 | N/A | N/A | $0 |
| 06/30/2025 | Q2 2025 | N/A | -$0.56 | N/A | N/A | $0 |
| 03/30/2025 | Q1 2025 | N/A | -$0.40 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Attovia Therapeutics Inc. Earnings: FAQ's
The conference call for Attovia Therapeutics Inc.'s latest earnings report can be listened to online.
The conference call transcript for Attovia Therapeutics Inc.'s latest earnings report can be read online.
Attovia Therapeutics Inc. (:ATTO) has a recorded annual revenue of $1.35 M.
Attovia Therapeutics Inc. (:ATTO) has a recorded net income of $-60,627,000.Attovia Therapeutics Inc. has generated $-1.42 earnings per share over the last four quarters.
Attovia Therapeutics Inc. (:ATTO) has a price-to-earnings ratio of -16.17 and price/earnings-to-growth ratio is 0.2.